肝癌术后抗乙型肝炎病毒治疗对预防肝癌复发的研究  

Research on Anti-hepatitis B Virus Treatment after Liver Cancer Operation in Predicting the Recurrence of Liver Cancer

作　　者：刘春铭 

机构地区：[1]黑龙江省农垦红兴隆管理局中心医院普外三科,黑龙江双鸭山155811

出　　处：《中外医疗》2016年第14期111-112,共2页China & Foreign Medical Treatment

摘　　要：目的探讨肝癌术后抗乙型肝炎病毒治疗对预防肝癌复发的效果。方法方便选取该院2012年4月—2014年8月收治的乙型肝癌病毒复制的肝癌患者80例,随机分为对照组(40例)和观察组(40例),其中对照组患者单纯采取手术治疗,观察组患者肝癌术后,采取相应抗病毒治疗,比较两组患者治疗一年后的肝功能以及复发率。结果经过治疗一年后,观察组患者的肝功能AST、ALT、TBIL和ALB分别为(71.42±3.51)U/L、(64.36±2.48)U/L、(51.15±2.11)μmol/L和(38.85±2.46)g/L,数据均优于对照组患者,且观察组患者复发率仅为5%,明显低于对照组患者(P<0.05)。结论肝癌术后,对患者采取抗病毒治疗能够改善患者肝功能,降低复发率。Objective To discuss the effect of anti-hepatitis B virus treatment after liver cancer operation in predicting the recurrence of liver cancer. Methods 80 cases of patients with liver cancer replicated by hepatitis B virus of liver cancer admitted and treated in our hospital from April 2012 to August 2014 were selected and randomly divided into two groups with40 cases in each, the control group were treated with simple operation, the observation group were treated with corresponding anti-virus after liver cancer operation, and the liver functions and recurrence rates of the two groups were compared after 1-year treatment. Results After 1-year treatment, the liver function AST, ALT, TBIL and ALB in the observation group were respectively（71.42±3.51） U/L,（64.36±2.48） U/L,（51.15±2.11） μmol/L and（38.85±2.46） g/L, which were better than those in the control group, and the recurrence rate in the observation group was only 5%, which was obviously lower than that in the control group, P〈0.05. Conclusion After the liver cancer operation, the anti-virus treatment can improve the liver function of patients and reduce the recurrence rate.

关 键 词：肝癌 乙型抗炎病毒 治疗 复发 

分 类 号：R61[医药卫生—外科学]